Craft

Dare Bioscience

Stock Price

$0.6

2023-09-08

Market Capitalization

$57.6 M

2023-09-08

Revenue

$10 M

FY, 2022

Dare Bioscience Summary

Company Summary

Overview
Dare Bioscience (formerly Cerulean Pharma) is a clinical-stage oncology-focused company developing nanoparticle-drug conjugates, is committed to improving treatment for people living with cancer. The Company applies Dynamic Tumor Targeting Platform to create a growing portfolio of nanoparticle-drug conjugate designed to selectively attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations.
Type
Public
Status
Active
Founded
2006
HQ
San Diego, CA, US | view all locations
Website
https://www.darebioscience.com
Cybersecurity rating
Sectors

Key People

  • Susan L. Kelley

    Susan L. Kelley, Director

    • Jessica Grossman

      Jessica Grossman, Director

      • William H. Rastetter

        William H. Rastetter, Chairman of the Board

        • Sabrina Martucci Johnson

          Sabrina Martucci Johnson, President and Chief Executive Officer, Director

        LocationsView all

        1 location detected

        • San Diego, CA HQ

          United States

          3655 Nobel Dr #260

        Dare Bioscience Financials

        Summary Financials

        Net income (Q2, 2023)
        ($8.8M)
        Cash (Q2, 2023)
        $13.3M
        EBIT (Q2, 2023)
        ($9.0M)
        Enterprise value
        $44.6M

        Footer menu